NEW YORK (dpa-AFX) – Further interest rate hikes expected by the US Federal Reserve weighed on US stock markets on Wednesday. The main Dow Jones Industrial index
At its December meeting, the Fed raised interest rates by half a percentage point, as widely expected, slowing the pace of rate hikes – it had previously hiked interest rates four times in a row by 0.75 percentage point. However, the monetary watchdogs apparently don’t intend to end their fight against inflation anytime soon. For 2023, they report even more interest rate hikes than before. Monetary policy will likely ease in the years to come. According to forecasts, however, there are signs of a higher level of interest rates than previously promised by central bankers.
Among the individual values, Moderna stood out on Wednesday
up more than 7 percent to $211.70 as a leader on the Nasdaq 100. Shares of the biotech company had risen a day earlier on positive study results of a combination therapy consisting of a cancer vaccine Moderna and the anticancer drug pembrolizumab from Merck & Co.
it crossed the $200 mark for the first time since mid-January. And like the day before, the stocks of Mainz competitor Biontech moved
Meanwhile, the previous day’s Nasdaq was Tesla’s latest
However, Charter Communications took over the red lantern in the tech-savvy selection index mid-week
On the other hand, Delta Air Lines newspapers put
ISIN US2605661048 US6311011026 US78378X1072
AXC0333 2022-12-14/20:46
Copyright dpa-AFX business news GmbH. All rights reserved. Redistribution, republication or permanent archiving without the prior express consent of dpa-AFX is not permitted.